Icares Medicus (Taiwan) Analysis
| 6612 Stock | TWD 125.50 4.50 3.72% |
Icares Medicus is fairly valued with Real Value of 127.63 and Hype Value of 125.5. The main objective of Icares Medicus stock analysis is to determine its intrinsic value, which is an estimate of what Icares Medicus is worth, separate from its market price. There are two main types of Icares Medicus' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Icares Medicus' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Icares Medicus' stock to identify patterns and trends that may indicate its future price movements.
The Icares Medicus stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Icares Medicus is usually not traded on Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2, Mid - autumn / Moon Festival. Icares Stock trading window is adjusted to Asia/Taipei timezone.
Icares |
Icares Stock Analysis Notes
About 54.0% of the company shares are owned by insiders or employees . The book value of Icares Medicus was presently reported as 25.38. The company last dividend was issued on the 7th of April 2022. Icares Medicus had 1000:1100 split on the 7th of July 2024. ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan. For more info on Icares Medicus please contact IhHoung Loh at 886 3 657 9530 or go to https://www.icaresmedicus.com.Icares Medicus Investment Alerts
| Icares Medicus is not yet fully synchronised with the market data | |
| About 54.0% of the company shares are owned by insiders or employees |
Icares Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Icares Medicus's market, we take the total number of its shares issued and multiply it by Icares Medicus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Icares Profitablity
Icares Medicus' profitability indicators refer to fundamental financial ratios that showcase Icares Medicus' ability to generate income relative to its revenue or operating costs. If, let's say, Icares Medicus is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Icares Medicus' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Icares Medicus' profitability requires more research than a typical breakdown of Icares Medicus' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28. Icares Medicus Outstanding Bonds
Icares Medicus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Icares Medicus uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Icares bonds can be classified according to their maturity, which is the date when Icares Medicus has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
About Icares Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Icares Medicus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Icares shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Icares Medicus. By using and applying Icares Stock analysis, traders can create a robust methodology for identifying Icares entry and exit points for their positions.
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Icares Medicus to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Additional Tools for Icares Stock Analysis
When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.